Utilization of health care databases for pharmacoepidemiology

European Journal of Clinical Pharmacology

Volumn 68, Issue 2, 2012, Pages 123-129

  Takahashi, Yasuo ^a   Nishida, Yayoi ^a   Asai, Satoshi ^a  

^a NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Comparative effectiveness; Health care database; Observational database study; Pharmacoepidemiology; Propensity score analysis

Indexed keywords

COMPARATIVE EFFECTIVENESS; COST EFFECTIVENESS ANALYSIS; DATA BASE; DRUG INFORMATION; DRUG SURVEILLANCE PROGRAM; DRUG UTILIZATION; HEALTH CARE DATABASE; HEALTH CARE DELIVERY; JAPAN; OBSERVATIONAL STUDY; PATIENT SAFETY; PHARMACOEPIDEMIOLOGY; POSTMARKETING SURVEILLANCE; PRIORITY JOURNAL; PRIVACY; PROPENSITY SCORE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW;

DATABASES, FACTUAL; DELIVERY OF HEALTH CARE; HUMANS; PHARMACOEPIDEMIOLOGY; RESEARCH DESIGN; TREATMENT OUTCOME;

EID: 84857045841     PISSN: 00316970     EISSN: 14321041     Source Type: Journal    
DOI: 10.1007/s00228-011-1088-2     Document Type: Review

References (30)

1. Guidelines for good pharmacoepidemiology practices (GPP) (2008) Pharmacoepidemiol Drug Saf 17 (2):200-208
2. SL Silverman 2009 From randomized controlled trials to observational studies Am J Med 122 2 114 120 19185083 10.1016/j.amjmed.2008.09.030
3. IC Wong ML Murray 2005 The potential of UK clinical databases in enhancing paediatric medication research Br J Clin Pharmacol 59 6 750 755 15948943 10.1111/j.1365-2125.2005.02450.x (Pubitemid 40838627)
4. NA Dreyer S Schneeweiss BJ McNeil ML Berger AM Walker DA Ollendorf RE Gliklich 2010 GRACE principles: recognizing high-quality observational studies of comparative effectiveness Am J Manag Care 16 6 467 471 20560690
5. M Trojano F Pellegrini D Paolicelli A Fuiani V Di Renzo 2009 Observational studies: propensity score analysis of non-randomized data Int MS J 16 3 90 97 19878631 1:STN:280:DC%2BD1MjjtVKitw%3D%3D
6. J Concato N Shah RI Horwitz 2000 Randomized, controlled trials, observational studies, and the hierarchy of research designs N Engl J Med 342 25 1887 1892 10861325 10.1056/NEJM200006223422507 1:STN:280:DC%2BD3czgt1Chsw%3D%3D (Pubitemid 30419054)
7. ML Berger M Mamdani D Atkins ML Johnson 2009 Good research practices for comparative effectiveness research: defining, reporting and interpreting nonrandomized studies of treatment effects using secondary data sources: the ISPOR Good Research Practices for Retrospective Database Analysis Task Force Report-part I Value Health 12 8 1044 1052 19793072 10.1111/j.1524-4733.2009. 00600.x
8. E Cox BC Martin T Van Staa E Garbe U Siebert ML Johnson 2009 Good research practices for comparative effectiveness research: approaches to mitigate bias and confounding in the design of nonrandomized studies of treatment effects using secondary data sources: the International Society for Pharmacoeconomics and Outcomes Research Good Research Practices for Retrospective Database Analysis Task Force Report-part I Value Health 12 8 1053 1061 19744292 10.1111/j.1524-4733.2009.00601.x
9. ML Johnson W Crown BC Martin CR Dormuth U Siebert 2009 Good research practices for comparative effectiveness research: analytic methods to improve causal inference from nonrandomized studies of treatment effects using secondary data sources: the ISPOR Good Research Practices for Retrospective Database Analysis Task Force Report-part II Value Health 12 8 1062 1073 19793071 10.1111/j.1524-4733.2009.00602.x
10. S Schneeweiss J Avorn 2005 A review of uses of health care utilization databases for epidemiologic research on therapeutics J Clin Epidemiol 58 4 323 337 15862718 10.1016/j.jclinepi.2004.10.012 (Pubitemid 40601980)
11. S Hennessy 2006 Use of health care databases in pharmacoepidemiology Basic Clin Pharmacol Toxicol 98 3 311 313 16611207 10.1111/j.1742-7843.2006.pto- 368.x 1:CAS:528:DC%2BD28XjsVWmsLc%3D
12. BL Strom JL Carson AC Halpern R Schinnar ES Snyder PD Stolley M Shaw HH Tilson M Joseph WS Dai, et al. 1991 Using a claims database to investigate drug-induced Stevens-Johnson syndrome Stat Med 10 4 565 576 2057655 10.1002/sim.4780100408 1:STN:280:DyaK3M3otVWksw%3D%3D
13. Freedman AN, Sansbury LB, Figg WD, Potosky AL, Weiss Smith SR, Khoury MJ, Nelson SA, Weinshilboum RM, Ratain MJ, McLeod HL, Epstein RS, Ginsburg GS, Schilsky RL, Liu G, Flockhart DA, Ulrich CM, Davis RL, Lesko LJ, Zineh I, Randhawa G, Ambrosone CB, Relling MV, Rothman N, Xie H, Spitz MR, Ballard-Barbash R, Doroshow JH, Minasian LM (2010) Cancer pharmacogenomics and pharmacoepidemiology: setting a research agenda to accelerate translation. J Natl Cancer Inst 102:1-8
14. RG Arnold JG Kotsanos 1999 Panel 3: methodological issues in conducting pharmacoeconomic evaluations-retrospective and claims database studies Value Health 2 2 82 87 16674338 10.1046/j.1524-4733.1999.02204.x 1:STN:280: DC%2BD283ltFGhtA%3D%3D
15. HT Sorensen S Sabroe J Olsen 1996 A framework for evaluation of secondary data sources for epidemiological research Int J Epidemiol 25 2 435 442 9119571 10.1093/ije/25.2.435 1:STN:280:DyaK2s%2FhsVGguw%3D%3D (Pubitemid 26137126)
16. B Motheral J Brooks MA Clark WH Crown P Davey D Hutchins BC Martin P Stang 2003 A checklist for retrospective database studies-report of the ISPOR Task Force on Retrospective Databases Value Health 6 2 90 97 12641858 10.1046/j.1524-4733.2003.00242.x (Pubitemid 36403125)
17. LI Iezzoni 1997 Assessing quality using administrative data Ann Intern Med 127 8 Pt 2 666 674 9382378 1:STN:280:DyaK2svmvVKjsw%3D%3D
18. RJ Glynn S Schneeweiss T Sturmer 2006 Indications for propensity scores and review of their use in pharmacoepidemiology Basic Clin Pharmacol Toxicol 98 3 253 259 16611199 10.1111/j.1742-7843.2006.pto-293.x 1:CAS:528: DC%2BD28XjsVWmsL8%3D
19. RB D'Agostino Jr 1998 Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group Stat Med 17 19 2265 2281 9802183 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0. CO;2-B (Pubitemid 28466823)
20. DB Rubin 1997 Estimating causal effects from large data sets using propensity scores Ann Intern Med 127 8 Pt 2 757 763 9382394 1:STN:280: DyaK2svmvVKitQ%3D%3D (Pubitemid 27446562)
21. S Weitzen KL Lapane AY Toledano AL Hume V Mor 2004 Principles for modeling propensity scores in medical research: a systematic literature review Pharmacoepidemiol Drug Saf 13 12 841 853 15386709 10.1002/pds.969 (Pubitemid 40003819)
22. BR Shah A Laupacis JE Hux PC Austin 2005 Propensity score methods gave similar results to traditional regression modeling in observational studies: a systematic review J Clin Epidemiol 58 6 550 559 15878468 10.1016/j.jclinepi. 2004.10.016 (Pubitemid 40692720)
23. JM McWilliams E Meara AM Zaslavsky JZ Ayanian 2007 Use of health services by previously uninsured Medicare beneficiaries N Engl J Med 357 2 143 153 17625126 10.1056/NEJMsa067712 1:CAS:528:DC%2BD2sXnslSjsbo%3D (Pubitemid 47057732)
24. AZ Fu GG Liu DB Christensen RA Hansen 2007 Effect of second-generation antidepressants on mania- and depression-related visits in adults with bipolar disorder: a retrospective study Value Health 10 2 128 136 17391421 10.1111/j.1524-4733.2006.00159.x (Pubitemid 46481139)
25. A Linden JL Adams 2010 Evaluating health management programmes over time: application of propensity score-based weighting to longitudinal data J Eval Clin Pract 16 1 180 185 20367830 10.1111/j.1365-2753.2009.01361.x
26. Leslie S, Thiebaud P (2007) Using propensity score to adjust for treatment selection bias. SAS global forum 2007 paper 184. http://www2.sas.com/ proceedings/forum2007/184-2007.pdf. Accessed 16 March 2011
27. BV Patel RS Leslie P Thiebaud MB Nichol SS Tang H Solomon D Honda JM Foody 2008 Adherence with single-pill amlodipine/atorvastatin vs a two-pill regimen Vasc Health Risk Manag 4 3 673 681 18827917 1:CAS:528: DC%2BD1cXpt1ajurY%3D (Pubitemid 352037925)
28. Y Nishida Y Takahashi T Nakayama M Soma N Kitamura S Asai 2010 Effect of candesartan monotherapy on lipid metabolism in patients with hypertension: a retrospective longitudinal survey using data from electronic medical records Cardiovasc Diabetol 9 38 20712859 10.1186/1475-2840-9-38
29. N Kitamura Y Takahashi S Yamadate S Asai 2007 Angiotensin II receptor blockers decreased blood glucose levels: a longitudinal survey using data from electronic medical records Cardiovasc Diabetol 6 26 17903269 10.1186/1475-2840-6-26 (Pubitemid 350193889)
30. S Schneeweiss 2007 Developments in post-marketing comparative effectiveness research Clin Pharmacol Ther 82 2 143 156 17554243 10.1038/sj.clpt.6100249 1:STN:280:DC%2BD2svhtFSlsQ%3D%3D (Pubitemid 47075343)